Minimal Hepatic Encephalopathy: Effect of H. pylori infection and small intestinal bacterial overgrowth treatment on clinical outcomes.

Abstract

The effect Helicobacter pylori (Hp) infection and small intestinal bacterial over growth (SIBO) in minimal hepatic encephalopathy (MHE) is not well understood. The aim of the study was to determine the effect of eradication of Hp infection and SIBO treatment on MHE in patients with cirrhosis. Patients with cirrhosis were enrolled and MHE was determined by psychometric tests and critical flicker frequency analysis. Hp infection and SIBO were assessed by urea breath and Hydrogen breath tests respectively in patients with cirrhosis and in healthy volunteers. Patients with Hp infection and SIBO were given appropriate treatment. At six weeks follow-up, presence of Hp infection, SIBO and MHE status was reassessed. Ninety patients with cirrhosis and equal number of healthy controls were included. 55 (61.1%) patients in the cirrhotic group were diagnosed to have underlying MHE. Among cirrhotic group, Hp infection was present in 28 with MHE (50.9%) vs. in 15 without MHE (42.8%) (p = 0.45). Similarly, SIBO was present in 17 (30.9%) vs. 11 (31.4%) (p = 0.95) in patients with and without MHE respectively. In comparison with healthy controls, patients with cirrhosis were more frequently harboring Hp and SIBO (47.7% vs. 17.7% (p < 0.001) and 31.1% vs. 4.4% (p < 0.001) respectively. On follow-up, all patients showed evidence of eradication of Hp and SIBO infection. Treatment of SIBO significantly improved the state of MHE in cirrhotics, however eradication of Hp infection did not improve MHE significantly. Additionally, patients with low Model for End-Stage Liver Disease (MELD) score and belonging to Child class B had significantly better improvement in MHE. A large number of patients with cirrhosis had either active Hp infection or SIBO with or without MHE, compared to healthy controls. Treatment of SIBO significantly improved MHE in patients with cirrhosis, whereas eradication of Hp did not affect the outcome of MHE in these patients.

• Authors: Shahab Abid, Muhammad Kamran, Adeel Abid, Nazish Butt, Safia Awan, Zaigham Abbas
• Journal: Scientific reports (Sci Rep) Vol. 10 Issue 1 Pg. 10079 (06 22 2020) ISSN: 2045-2322 [Electronic] England
• PMID: 32572109 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Topics

• Adult
• Bacterial Infections
• Case-Control Studies
• Dysbiosis (metabolism)
• Female
• Gastrointestinal Diseases (microbiology)
• Helicobacter Infections (microbiology)
• Helicobacter pylori (metabolism, pathogenicity)
• Hepatic Encephalopathy (complications, microbiology, surgery)
• Humans
• Liver (microbiology, pathology)
• Liver Cirrhosis (microbiology)
• Liver Function Tests
• Male
• Middle Aged
• Psychometrics (methods)
• Severity of Illness Index
• Treatment Outcome